Kelleher Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
2,498
+1,628
+187% +$1.66M 0.43% 51
2026
Q1
$786K Buy
870
+188
+28% +$191K 0.2% 82
2025
Q4
$733K Sell
682
-101
-13% -$96.6K 0.17% 90
2025
Q3
$597K Buy
783
+316
+68% +$235K 0.15% 95
2025
Q2
$364K Hold
467
– – 0.13% 98
2025
Q1
$385K Sell
467
-6
-1% -$4.99K 0.15% 88
2024
Q4
$365K Buy
473
+107
+29% +$88.6K 0.14% 89
2024
Q3
$324K Hold
366
– – 0.12% 92
2024
Q2
$331K Sell
366
-10
-3% -$8K 0.14% 88
2024
Q1
$293K Hold
376
– – 0.12% 100
2023
Q4
$219K Hold
376
– – 0.1% 91
2023
Q3
$202K Buy
+376
New +$194K 0.1% 99

Other funds holding LLY

Kelleher Financial Advisors's LLY Position: Q2 2026 in Review

Kelleher Financial Advisors increased its Eli Lilly (LLY) stake by 187% in Q2 2026, buying an estimated $1.66M and bringing the position to 2,498 shares worth $3M. The position accounts for 0.43% of the portfolio, ranked #51.

Kelleher Financial Advisors first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kelleher Financial Advisors held 2,498 shares of Eli Lilly worth $3M as of Q2 2026.
  • Kelleher Financial Advisors bought 1,628 Eli Lilly shares in Q2 2026, an estimated $1.66M.
  • Eli Lilly made up 0.43% of Kelleher Financial Advisors's portfolio in Q2 2026, its #51 holding.
  • Kelleher Financial Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.